VITREX MEDICAL A/S: Financial statements 2013
CVR: 14728732
Source: annual report 2013, Danish Business Authority
01/05/2012 – 30/04/2013
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 14,668,448 and a net result of DKK 3,881,800. Equity in the 2013 report amounted to DKK 13,269,533. The solvency ratio was 43.6%.
- Gross Profit
- DKK 14,668,448
- Profit/Loss
- DKK 3,881,800
- Equity
- DKK 13,269,533
- Total Assets
- DKK 30,463,531
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of January 14, 2013, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of VITREX MEDICAL A/S.
As of January 14, 2013, Bjarne Albrechtsen has stepped down as auditor of VITREX MEDICAL A/S.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.